Nicotinic receptors as CNS targets for Parkinson's disease
- 15 October 2007
- journal article
- review article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 74 (8), 1224-1234
- https://doi.org/10.1016/j.bcp.2007.06.015
Abstract
No abstract availableKeywords
This publication has 122 references indexed in Scilit:
- Nicotine partially protects against paraquat-induced nigrostriatal damage in mice; link to α6β2* nAChRsJournal of Neurochemistry, 2007
- Nicotinic receptor agonists as neuroprotective/neurotrophic drugs. Progress in molecular mechanismsJournal of Neural Transmission, 2006
- Partial Recovery of Striatal Nicotinic Receptors in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-Lesioned Monkeys with Chronic Oral NicotineThe Journal of pharmacology and experimental therapeutics, 2006
- Diagnosis and treatment of Parkinson disease: molecules to medicineJCI Insight, 2006
- Aging of the nigrostriatal system in the squirrel monkeyJournal of Comparative Neurology, 2004
- l-DOPA Treatment Modulates Nicotinic Receptors in Monkey StriatumMolecular Pharmacology, 2003
- Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]α‐bungarotoxin binding sites in the brain of Macaca mulattaJournal of Comparative Neurology, 2003
- (S)-(−)-5-Ethynyl-3-(1-methyl-2-pyrroli- dinyl)pyridine Maleate (SIB-1508Y): A Novel Anti-Parkinsonian Agent with Selectivity for Neuronal Nicotinic Acetylcholine ReceptorsJournal of Medicinal Chemistry, 1996
- Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spuriousBritish Medical Bulletin, 1996
- Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatumBrain Research, 1989